Account Executive - New England
IDMWORKSFull Time
Entry Level & New Grad
Candidates should possess a B.S. in life science, biology, business, or marketing, with an MBA preferred. A proven track record of revenue generation in diagnostics, pharmaceuticals, or biotechnology is essential, along with at least 3 years of direct account management experience in molecular diagnostics, ideally with a focus on MRD testing. Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices is required. The role demands proven ability in consultative selling of integrated molecular diagnostic solutions, comfort engaging with executive-level stakeholders, and an in-depth understanding of the payer and reimbursement environment in oncology diagnostics. Strong independent work ethic, communication, project management, prioritization skills, knowledge of molecular diagnostics and MRD testing, proficiency in Microsoft Office and Salesforce.com, and the ability to develop cross-functional relationships are also necessary. Advanced presentation skills and business acumen are required, with the ability to work effectively with minimal direction.
The MRD Clinical Account Executive will drive the adoption of Tempus's MRD testing services within their territory, engaging with KOLs, clinicians, and decision-makers to establish and expand business opportunities. Responsibilities include developing strategic plans for client acquisition and retention, maximizing client-bill contracting, and implementing laboratory services agreements. The role involves collaborating with various sales roles to achieve company goals, identifying partnership opportunities, and providing market feedback to leadership. A comprehensive business plan for the territory, including budgets and goal setting, must be developed and implemented. The individual will represent Tempus's company culture with integrity, respect, and trust.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.